What is BPC-157? A Researcher's Guide

BPC-157 — Body Protection Compound 157 — is a synthetic pentadecapeptide comprising 15 amino acids derived from a partial sequence of human gastric juice protein BPC. First isolated in the 1990s, it has since become one of the most studied peptide compounds in preclinical tissue-repair and gastrointestinal research. This guide covers what the compound is, how it has been studied, and what researchers should know before working with it.

Molecular Identity and Stability

BPC-157 has the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight of approximately 1419.5 Da. Unlike many peptides, BPC-157 demonstrates notable stability across a range of pH environments and has been used in both aqueous and acidic model systems without significant degradation. It is typically supplied as a lyophilized powder for reconstitution with bacteriostatic water prior to use in in vitro or preclinical protocols.

Research Applications and Study Models

The preponderance of BPC-157 research has been conducted in rodent models examining tissue repair, mucosal healing, and inflammatory signaling. Studies published in peer-reviewed journals have investigated its effects on gastrointestinal integrity — specifically mucosal ulcer models, inflammatory bowel models, and anastomotic healing. Separately, a body of preclinical work has explored its activity in musculoskeletal models involving tendon and ligament tissue, where researchers have observed upregulation of growth factor receptor expression and angiogenic signaling markers.

Mechanisms Under Investigation

BPC-157's proposed mechanisms center on modulation of the nitric oxide (NO) system, interaction with growth hormone receptor pathways, and upregulation of vascular endothelial growth factor (VEGF). In gastrointestinal research specifically, it appears to influence FAK-paxillin and EGR-1 expression. Researchers have also studied its interaction with the dopaminergic and serotonergic systems in CNS models, though this line of inquiry remains early-stage. It is critical to note that all of these mechanisms have been characterized in in vitro cell cultures or animal models — no clinical data exists.

Important Research Considerations

BPC-157 has not been approved by the FDA or any regulatory agency for use in humans. All published mechanistic data originates from controlled preclinical settings. Researchers designing protocols with BPC-157 should reference the primary literature directly and treat all published findings as model-specific. Purity and batch consistency are critical variables — researchers should request a Certificate of Analysis confirming HPLC purity and mass spectrometry identity verification before use.

PeptoBuy supplies research-grade BPC-157 as a lyophilized powder (10 mg per vial) for qualified researchers and laboratories. Each batch is independently third-party tested with COA available on request. For in vitro research use only — not for human or animal consumption.